Leading companies share digital strategies and best practices for accelerating time to market PLEASANTON, Calif., Sept. 8, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its 2022...

Kintara Therapeutics, Inc.(Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that three...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Dr. Samarendra Mohanty, Co-Founder and...

Company to Present Corporate Update During Investor Conference, Sept. 14, 2022, at 9:00am ET RADNOR, Pa., Sept. 8, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage...

Findings from nine studies across a breadth of tumor types and genomic alterations demonstrate the clinical benefits delivered by Caris' whole exome, whole transcriptome approach to molecular...